MedTrace Logo

Plasma B-Type Natriuretic Peptide Concentrations in Preterm Infants < 28 Weeks

NCT00528736 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2007-09-14

No results posted yet for this study

Summary

The aim of the study was to evaluate BNP in preterm infants \< 28 weeks on the second day of life, when it is still unknown, if a patent ductus arteriosus is hemodynamic significant or not. We hypothesized that high plasma BNP concentrations on day 2 are associated with the need of PDA intervention in the further course.

Conditions

  • Infant, Premature
  • Ductus Arteriosus, Patent
  • Natriuretic Peptide Brain

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Christoph Czernik, MD · Department of Neonatology, Charite Virchow Hospital, Medical University Berlin

Eligibility

Min Age
24 Hours
Max Age
48 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Completion
2007-04-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00528736 on ClinicalTrials.gov